MMedication Read More FDA Confirms Direct Review Path For Aquestive’s Allergy TreatmentSeptember 4, 2025 The U.S. Food and Drug Administration (FDA) on Thursday informed Aquestive Therapeutics, Inc. (NASDAQ:AQST) that an advisory committee…